Clinical Trials for Pulmonary embolism
Clinical trials are research studies conducted in an effort to improve overall patient health and care.
Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition.
Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks.
A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.
A brief description of each phase:
- Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
- Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
- Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
- Phase IV: These studies monitor long-term side effects after the treatment has been marketed.
Clinical Trials data for Pulmonary embolism is grouped into the following categories:-
The format for each of the following is:
- The name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
- followed by a list of drug/s, if any, used in the trial
ClinicalTrials.gov has listed the following trials for Pulmonary embolism:
- 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE - This study has been completed (Current: 23 Nov 2006) - Duration of anticoagulation,Warfarin duration
- ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) - This study is no longer recruiting patients (Current: 23 Nov 2006) - SB-424323
- Multi-Detector Spiral Computed Tomography Alone Versus Combined Strategy With Lower Limb Compression Ultrasonography in Outpatients Suspected of Pulmonary Embolism - This study is currently recruiting patients (Current: 23 Nov 2006)
- D-Dimer and IPG for Recurrent Thrombosis (DIRECT) - This study has been terminated (Current: 23 Nov 2006)
- Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure - This study is currently recruiting patients (Current: 23 Nov 2006) - Tinzaparin
- The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial - This study is currently recruiting patients (Current: 23 Nov 2006) - Low Molecular Weight Heparin (dalteparin)
- Strategies for Pulmonary Embolism in Emergency Departments - This study is currently recruiting patients (Current: 23 Nov 2006)
- Study of IVC Filter Retrieval With the Gnther Tulip Vena Cava Filter - This study is currently recruiting patients (Current: 23 Nov 2006)
- Home Treatment of Pulmonary Embolism - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Tenecteplase Pulmonary Embolism Italian Study - This study is currently recruiting patients (Current: 23 Nov 2006) - tenecteplase
- Aspirin for the Prevention of Recurrent Venous Thromboembolism and Cardiovascular Events - This study is currently recruiting patients (Current: 23 Nov 2006) - aspirin
- Odiparcil For The Prevention Of Venous Thromboembolism - This study is currently recruiting patients (Current: 23 Nov 2006) - Odiparcil,Warfarin,Coumadin
- D-Dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence - This study is currently recruiting patients (Current: 23 Nov 2006)
- Study of Diagnosis and Pathophysiology of Pulmonary Embolism (APE 1 Trial) - This study is currently recruiting patients (Current: 23 Nov 2006)
- VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis - This study has been completed (Current: 23 Nov 2006) - 5 mg folic acid, 50 mg pyridoxine and 0.4 mg cyanocobalamin
- Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Fondaparinux
- Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux - This study is currently recruiting patients (Current: 23 Nov 2006)
- Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information. - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Warfarin
- Catheter Thrombectomy in Patients With Massive Pulmonary Embolism - This study is currently recruiting patients (Current: 23 Nov 2006)
- Deferment of Imaging for Pulmonary Embolism - This study has been completed (Current: 23 Nov 2006) - low molecular weight heparin
- BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery - This study is no longer recruiting patients (Current: 23 Nov 2006) - BMS-562247
- Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot - This study is currently recruiting patients (Current: 23 Nov 2006)
- Study of Apixaban for the Prevention of Thrombosis-Related Events Following Knee Replacement Surgery - This study is currently recruiting patients (Current: 23 Nov 2006) - Apixaban
- Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) - This study has been completed (Current: 23 Nov 2006)
- Nurses' Health Study - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Incidence and Outcomes of Venous Thromboembolism - This study has been completed (Current: 23 Nov 2006)
- Epidemiology of Venous Thrombosis and Pulmonary Embolism - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II) - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Risk Factors for Venous Thromboembolism - This study has been completed (Current: 23 Nov 2006)
- SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism - This study has been completed (Current: 23 Nov 2006) - SR34006,(LMW)heparin,Warfarin VKA,Acenocoumarol VKA
- SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis - This study has been completed (Current: 23 Nov 2006) - SR34006 (idraparinux sodium) Injection
- Identifying Low-Risk Patients With Pulmonary Embolism - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Genetic Determinants of Warfarin Anticoagulation Effect - This study is currently recruiting patients (Current: 23 Nov 2006) - Warfarin
- Fixed Dose Heparin Study - This study has been completed (Current: 23 Nov 2006) - UFH 250 U/kg or LMWH 100 U/kg sc twice daily
- SHORTness of Breath In the Emergency Department (SHORTIE) - This study has been completed (Current: 23 Nov 2006)
- The Cordis Protection From Pulmonary Embolism With the Permanent OptEase Filter A Post Marketing Surveillance Study (PROOF) - This study has been completed (Current: 23 Nov 2006)
- Prospective Investigation of Pulmonary Embolism Diagnosis III - This study is currently recruiting patients (Current: 23 Nov 2006)
- D-Dimer to Establish Duration of Anticoagulation After Venous Thromboembolism - This study has been completed (Current: 23 Nov 2006) - Vitamin K antagonist (Coumarin anticoagulants)
- Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Apixaban
- Detection of Pulmonary Embolism With CECT - This study is currently recruiting patients (Current: 23 Nov 2006) - Isovue
- Deep Vein Thrombosis (DVT) Prevention in Total Hip Replacement: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) - This study is currently recruiting patients (Current: 23 Nov 2006)
- Breath Analysis Technique to Diagnose Pulmonary Embolism - This study is currently recruiting patients (Current: 23 Nov 2006)
- Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) - This study has been terminated (Current: 23 Nov 2006)
- Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study - This study is currently recruiting patients (Current: 23 Nov 2006) - Drotrecogin Alfa (Activated),Enoxaparin,Placebo
- Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term Outcomes - This study is currently recruiting patients (Current: 23 Nov 2006)
- A Pharmacogenetic Study of Wafarin Dosing, "The COUMA-GEN Study" - This study is currently recruiting patients (Current: 23 Nov 2006) - Standard of care or genotyping dosing of warfarin dosing
- Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - dalteparin
- Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT) - This study is currently recruiting patients (Current: 23 Nov 2006)
- Safety of a Diagnostic Strategy With D-Dimer Testing for PE - This study is currently recruiting patients (Current: 23 Nov 2006)
- CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) - This study is currently recruiting patients (Current: 23 Nov 2006) - Bemiparin
- Understanding Risk Factors Involved in Developing a Second Blood Clot. - This study is currently recruiting patients (Current: 23 Nov 2006)
- Single Comprehensive Ultrasound to Rule Out DVT in High-Risk Patients - This study is currently recruiting patients (Current: 23 Nov 2006)
- CASSIOPEA-Clinical Study Assessing SSR126517E Injections Once-Weekly in Pulmonary Embolism Therapeutic Approach - This study is currently recruiting patients (Current: 23 Nov 2006) - SSR126517
The format for each of the following is:
- The drug,
- followed by the name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
ClinicalTrials.gov has listed the following drugs in trials for Pulmonary embolism:
The trial data on this page has been sourced from
"I authorize the release of any medical or other information necessary to process this claim." Do you recognize these words? You should, if...
Whenever you go to a hospital or clinic for a major procedure or diagnostic test, one of the many forms you are given to sign is an "informed...
Sexual contact can sometimes result in problems. An unwanted pregnancy or sexually transmitted diseases may be some of those consequences. But by...
Stress takes its toll by making us anxious, depressed and not able to function as fully as we'd like. What many don't know is that stress can...
See full list of 4 related videos
» Next page: Images relating to Pulmonary embolism
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
